A phase II trial evaluating the efficacy and safety of efavirenz in metastatic castration-resistant prostate cancer
about
The Reverse Transcriptase Encoded by LINE-1 Retrotransposons in the Genesis, Progression, and Therapy of CancerEfavirenz Has the Highest Anti-Proliferative Effect of Non-Nucleoside Reverse Transcriptase Inhibitors against Pancreatic Cancer CellsEnhanced expression of LINE-1-encoded ORF2 protein in early stages of colon and prostate transformationAntitumor effect of combination of the inhibitors of two new oncotargets: proton pumps and reverse transcriptase.Activation of LINE-1 Retrotransposon Increases the Risk of Epithelial-Mesenchymal Transition and Metastasis in Epithelial Cancer.LINE-1 in cancer: multifaceted functions and potential clinical implications.Cytotoxic effect of Efavirenz in BxPC-3 pancreatic cancer cells is based on oxidative stress and is synergistic with ionizing radiation.A LINE-1-encoded reverse transcriptase-dependent regulatory mechanism is active in embryogenesis and tumorigenesis.Thapsigargin induces apoptosis of prostate cancer through cofilin-1 and paxillin.
P2860
Q26767214-3A4DA26D-2DB2-40DB-857C-56F92245A509Q28548473-00682532-6691-49A2-8F49-58FA23C79C5DQ36782347-2F879852-CA0B-4DA6-89BB-3045A9169FC3Q37706150-8716DD9D-D15B-4FF9-BCFF-0E7EAAFE1514Q37741550-1D6B457E-3AA5-43E6-89C2-E63BB11183A3Q38579541-B5F16F06-0A05-473B-86E1-FBCCD5E84B49Q49726714-7C3629AA-33E0-4D05-91C7-69FC80DA569DQ50607573-20CAB5FB-6E69-4D79-8E74-1C9E3FCDBC8DQ55646216-76BE4FA8-5BD8-476E-826F-5B83731C52A0
P2860
A phase II trial evaluating the efficacy and safety of efavirenz in metastatic castration-resistant prostate cancer
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
A phase II trial evaluating th ...... tion-resistant prostate cancer
@en
A phase II trial evaluating th ...... tion-resistant prostate cancer
@nl
type
label
A phase II trial evaluating th ...... tion-resistant prostate cancer
@en
A phase II trial evaluating th ...... tion-resistant prostate cancer
@nl
prefLabel
A phase II trial evaluating th ...... tion-resistant prostate cancer
@en
A phase II trial evaluating th ...... tion-resistant prostate cancer
@nl
P2093
P1433
P1476
A phase II trial evaluating th ...... tion-resistant prostate cancer
@en
P2093
Alain Puech
Audrey Laroche-Clary
Caroline Lalet
Frank Priou
François Ichas
Jean-Marc Ferrero
Loic Mourey
Marina Pulido
Mireille Canal Raffin
Nadine Houédé
P304
P356
10.1634/THEONCOLOGIST.2014-0345
P577
2014-10-29T00:00:00Z